Switch theme
Sign up to access all valuation multiples
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Fuel Specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field service providers in the extraction of oil and gas. The Performance Chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.
1998
2.5K+
LTM Revenue $1.8B
LTM EBITDA $216M
$1.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Innospec has a last 12-month revenue (LTM) of $1.8B and a last 12-month EBITDA of $216M.
In the most recent fiscal year, Innospec achieved revenue of $1.8B and an EBITDA of $225M.
Innospec expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Innospec valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.8B | XXX | $1.8B | XXX | XXX | XXX |
| Gross Profit | $527M | XXX | $543M | XXX | XXX | XXX |
| Gross Margin | 29% | XXX | 29% | XXX | XXX | XXX |
| EBITDA | $216M | XXX | $225M | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| EBIT | $178M | XXX | $181M | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| Net Profit | $89.2M | XXX | $35.6M | XXX | XXX | XXX |
| Net Margin | 5% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 31, 2025, Innospec's stock price is $81.
Innospec has current market cap of $2.0B, and EV of $1.8B.
See Innospec trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.8B | $2.0B | XXX | XXX | XXX | XXX | $5.62 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 31, 2025, Innospec has market cap of $2.0B and EV of $1.8B.
Innospec's trades at 1.0x EV/Revenue multiple, and 7.8x EV/EBITDA.
Equity research analysts estimate Innospec's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Innospec has a P/E ratio of 22.6x.
See valuation multiples for Innospec and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.0B | XXX | $2.0B | XXX | XXX | XXX |
| EV (current) | $1.8B | XXX | $1.8B | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 8.1x | XXX | 7.8x | XXX | XXX | XXX |
| EV/EBIT | 9.9x | XXX | 9.7x | XXX | XXX | XXX |
| EV/Gross Profit | 3.3x | XXX | n/a | XXX | XXX | XXX |
| P/E | 22.6x | XXX | 56.6x | XXX | XXX | XXX |
| EV/FCF | 17.5x | XXX | 14.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialInnospec's last 12 month revenue growth is 3%
Innospec's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.1M for the same period.
Innospec's rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Innospec's rule of X is 20% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Innospec and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | 5% | XXX | 2% | XXX | XXX | XXX |
| Rule of 40 | 14% | XXX | 16% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 20% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.8M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 20% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Borouge | XXX | XXX | XXX | XXX | XXX | XXX |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Akzo Nobel | XXX | XXX | XXX | XXX | XXX | XXX |
| Avantium | XXX | XXX | XXX | XXX | XXX | XXX |
| DSM Firmenich | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Innospec acquired XXX companies to date.
Last acquisition by Innospec was XXXXXXXX, XXXXX XXXXX XXXXXX . Innospec acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Innospec founded? | Innospec was founded in 1998. |
| Where is Innospec headquartered? | Innospec is headquartered in United States of America. |
| How many employees does Innospec have? | As of today, Innospec has 2.5K+ employees. |
| Who is the CEO of Innospec? | Innospec's CEO is Mr. Patrick S. Williams. |
| Is Innospec publicy listed? | Yes, Innospec is a public company listed on NAS. |
| What is the stock symbol of Innospec? | Innospec trades under IOSP ticker. |
| When did Innospec go public? | Innospec went public in 1998. |
| Who are competitors of Innospec? | Similar companies to Innospec include e.g. Borouge, Fertiglobe, Akzo Nobel, Avantium. |
| What is the current market cap of Innospec? | Innospec's current market cap is $2.0B |
| What is the current revenue of Innospec? | Innospec's last 12 months revenue is $1.8B. |
| What is the current revenue growth of Innospec? | Innospec revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Innospec? | Current revenue multiple of Innospec is 1.0x. |
| Is Innospec profitable? | Yes, Innospec is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Innospec? | Innospec's last 12 months EBITDA is $216M. |
| What is Innospec's EBITDA margin? | Innospec's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of Innospec? | Current EBITDA multiple of Innospec is 8.1x. |
| What is the current FCF of Innospec? | Innospec's last 12 months FCF is $101M. |
| What is Innospec's FCF margin? | Innospec's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of Innospec? | Current FCF multiple of Innospec is 17.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
